4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ·Healthcare·Biotechnology
$10.21
+1.14%
Mkt Cap $532.17M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (16 analysts)
$33.00
Range $33.00 – $33.00
Implied Upside
+223.2%
Consensus $33.00 vs current $10.21